These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 14703897)

  • 1. Cinnarizine in migraine prophylaxis: efficacy, tolerability and predictive factors for therapeutic responsiveness. An open-label pilot trial.
    Rossi P; Fiermonte G; Pierelli F
    Funct Neurol; 2003; 18(3):155-9. PubMed ID: 14703897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Open-label trial of cinnarizine in migraine prophylaxis.
    Togha M; Ashrafian H; Tajik P
    Headache; 2006 Mar; 46(3):498-502. PubMed ID: 16618269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of cinnarizine in the prophylaxis of migraine headaches in children: an open, randomized comparative trial with propranolol.
    Togha M; Malamiri RA; Rashidi-Ranjbar N; Asa S; Mahvelati F; Ashrafi MR
    Acta Neurol Belg; 2012 Mar; 112(1):51-5. PubMed ID: 22427290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R; Schreiber C
    Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and tolerability of flunarizine in the prophylaxis of migraine.
    Centonze V; Tesauro P; Trizio T; Magrone D; Vino M; Macinagrossa G; Campanozzi F; Altomare E; Attolini E; Albano O
    Cephalalgia; 1985 May; 5 Suppl 2():165-8. PubMed ID: 3893737
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy and safety of cinnarizine in the prophylaxis of migraine in children: a double-blind placebo-controlled randomized trial.
    Ashrafi MR; Salehi S; Malamiri RA; Heidari M; Hosseini SA; Samiei M; Tavasoli AR; Togha M
    Pediatr Neurol; 2014 Oct; 51(4):503-8. PubMed ID: 25023977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of cinnarizine versus sodium valproate in migraine prophylaxis.
    Bostani A; Rajabi A; Moradian N; Razazian N; Rezaei M
    Int J Neurosci; 2013 Jul; 123(7):487-93. PubMed ID: 23311688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An open pilot study assessing the benefits of quetiapine for the prevention of migraine refractory to the combination of atenolol, nortriptyline, and flunarizine.
    Krymchantowski AV; Jevoux C; Moreira PF
    Pain Med; 2010 Jan; 11(1):48-52. PubMed ID: 20002594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Flunarizine--a new agent for migraine prevention. Results of a double-blind comparison with placebo].
    Frenken CW; Nuijten ST
    Fortschr Med; 1984 Mar; 102(12):349-51. PubMed ID: 6370811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cinnarizine in refractory migraine prophylaxis: efficacy and tolerability. A comparison with sodium valproate.
    Togha M; Rahmat Jirde M; Nilavari K; Ashrafian H; Razeghi S; Kohan L
    J Headache Pain; 2008 Apr; 9(2):77-82. PubMed ID: 18286231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cinnarizine and sodium valproate as the preventive agents of pediatric migraine: A randomized double-blind placebo-controlled trial.
    Amanat M; Togha M; Agah E; Ramezani M; Tavasoli AR; Azizi Malamiri R; Fashandaky F; Heidari M; Salehi M; Eshaghi H; Ashrafi MR
    Cephalalgia; 2020 Jun; 40(7):665-674. PubMed ID: 31707814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Open label study of intranasal sumatriptan (Imigran) for footballer's headache.
    McCrory P; Heywood J; Ugoni A
    Br J Sports Med; 2005 Aug; 39(8):552-4. PubMed ID: 16046342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Duration of migraine is a predictor for response to botulinum toxin type A.
    Eross EJ; Gladstone JP; Lewis S; Rogers R; Dodick DW
    Headache; 2005 Apr; 45(4):308-14. PubMed ID: 15836566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study.
    Aurora SK; Gawel M; Brandes JL; Pokta S; Vandenburgh AM;
    Headache; 2007 Apr; 47(4):486-99. PubMed ID: 17445098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Montelukast for migraine prophylaxis: a randomized, double-blind, placebo-controlled study.
    Brandes JL; Visser WH; Farmer MV; Schuhl AL; Malbecq W; Vrijens F; Lines CR; Reines SA;
    Headache; 2004 Jun; 44(6):581-6. PubMed ID: 15186302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zolmitriptan nasal spray exhibits good long-term safety and tolerability in migraine: results of the INDEX trial.
    Dowson AJ; Charlesworth BR; Green J; Färkkilä M; Diener HC; Hansen SB; Gawel M;
    Headache; 2005 Jan; 45(1):17-24. PubMed ID: 15663608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of flunarizine in altering electronystagmographic patterns in migraine patients: a preliminary report.
    Pini LA; Ferrari A; Guidetti G; Galetti G; Barbieri L; Sternieri E
    Int J Clin Pharmacol Res; 1986; 6(1):27-32. PubMed ID: 3957502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized double-blind placebo-controlled trial of thioctic acid in migraine prophylaxis.
    Magis D; Ambrosini A; Sándor P; Jacquy J; Laloux P; Schoenen J
    Headache; 2007 Jan; 47(1):52-7. PubMed ID: 17355494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of increase in phosphene threshold with reduction of migraine frequency: observation of levetiracetam-treated subjects.
    Young W; Shaw J; Bloom M; Gebeline-Myers C
    Headache; 2008; 48(10):1490-8. PubMed ID: 19076647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nebivolol and metoprolol for treating migraine: an advance on beta-blocker treatment?
    Schellenberg R; Lichtenthal A; Wöhling H; Graf C; Brixius K
    Headache; 2008 Jan; 48(1):118-25. PubMed ID: 18184294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.